Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters
This study found increased cyclooxygenase-2 expression in the ovarian endometriotic cyst wall compared to other sites, but no correlation with clinico-pathological parameters or patient symptoms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
- Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts via openalex
- Deep endometriosis conundrum: evidence in favor of a peritoneal origin via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis via openalex
- Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis via openalex
- Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis via openalex
- The aetiology of endometriosis via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2043707891 via openalex
- W2110844151 via openalex
- W2039274017 via openalex
- W2127558096 via openalex
- W2029790299 via openalex
- W2146708145 via openalex
- W2019881493 via openalex
- W2238870413 via openalex
- W2346704459 via openalex
- W1966927722 via openalex
- W1865550052 via openalex
- W2097865940 via openalex
- W2477008945 via openalex
- W2109322259 via openalex
Cited by (48)
- Pathophysiology of Endometriosis: Insights from Immunohistochemical Analysis of Ectopic and Eutopic Tissues 2025
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium 2024
- Hypoxia-hindered methylation of PTGIS in endometrial stromal cells accelerates endometriosis progression by inducing CD16- NK-cell differentiation 2022
- Endometriosis Research: From Bench to Bedside 2022
- Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4 2021
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Peritoneal Fluid Cytokines Reveal New Insights of Endometriosis Subphenotypes 2020
- Molecular Mechanisms Underlying Adolescent Endometriosis and Advancements in Medical Management 2020
- Synchronous primary endometrial and ovarian cancers: how to diagnose, differentiate and treat in the light of recent available literature data 2020
- Reduced inflammatory state promotes reinnervation of endometriotic-like lesions in TNFRp55 deficient mice 2019
- Comparing The Effects of Glycyrrhiza glabra Root Extract, A Cyclooxygenase-2 Inhibitor (Celecoxib) and A Gonadotropin-Releasing Hormone Analog (Diphereline) in A Rat Model of Endometriosis 2019
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
- Predictive factors of ovarian endometrioma recurrence after laparoscopic excision: risk factors and prevention 2018
- [Immunohistochemical predictors of recurrent ovarian endometriomas after laparoscopic surgery] 2018
- The promising role of placental growth factor in association with cyclooxygenase-2 as predictive markers for recurrent ovarian endometriosis 2017
- Prostaglandin F2α-PTGFR signalling activation, growth factor expression and cell proliferation in bovine endometrial explants 2017
- Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis 2016
- COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis 2015
- Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence 2015
- Genetic variation in COX-2 -1195 and the risk of endometriosis and adenomyosis 2015
- Effects of Hominis Placenta Pharmacopuncture Therapy on the Experimentally-induced Endometriosis in the Rats 2014
- Role of Nerve Fibres in Endometriosis 2014
- Hormonal therapy deregulates prostaglandin-endoperoxidase synthase 2 (PTGS2) expression in endometriotic tissues 2013
- Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? 2012
- Implication of the RAGE-EN-RAGE axis in endometriosis 2010
- The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model 2010
- Expression of cyclooxygenase-2 in eutopic endometrium and ovarian endometriotic tissue in women with severe endometriosis 2009
- Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions 2009
- Involvement of iron, nuclear factor-kappa B (NF-KB) and prostaglandins in the pathogenesis of peritoneal endometriosis-associated inflammation: A review 2009
- Involvement of Iron, Nuclear Factor-Kappa B (NF-κB) and Prostaglandins in the Pathogenesis of Peritoneal Endometriosis-Associated Inflammation: A Review 2009
- Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence 2008
- Emerging drugs for endometriosis 2008
- Angiogenesis and antiangiogenic therapy in endometriosis 2007
- Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis? 2007
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin 2007
- Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells 2007
- Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells 2007
- Der derzeitige Stand der konservativen Therapie der Endometriose 2006
- A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice 2006
- Effects of Yiweining Recipe on expressions of metalloproteinase-2 and cyclooxygenase-2 mRNAs in ectopic endometrium of rats with endometriosis 2006
- Endometriosis: Current thinking 2006
- Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis 2005
- Endometriosi e cancro 2005
- COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain 2005
- Endometriosis: Current thinking 2005
- Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers? 2005
- Aromataseinhibitoren bei Endometriose? 2004
- Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis 2004
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:02:19.201584+00:00